Tuas FY26 slides: profit surges 328% as stock sinks near 52-week low
Source: Investing.com

Tuas reported FY26 revenue growth of 24% to SGD 187.6 million and a 328% surge in underlying net profit to SGD 29.6 million, but its shares fell 14.59% to $1.99 following the results. Investors focused on the lapsed M1 acquisition, an ongoing IMDA investigation into spectrum use, and expected FY27 incremental cybersecurity spending of SGD 15-30 million. The company retains strong operating metrics, including a 45% EBITDA margin, SGD 91 million of operating cash flow, and 16% mobile subscriber growth, but withheld specific FY27 EBITDA guidance amid regulatory and cost uncertainty.
Analysis
The structured ticker mapping is materially wrong: NDAQ has no economic exposure to Tuas/SIMBA, Singapore telecom regulation, or the proposed M1 transaction. This is therefore not an actionable NDAQ earnings or regulatory signal; any move in NDAQ should be evaluated through exchange volumes, listings activity, market-data demand, and U.S. regulatory developments—not this event. Suppress automated sentiment-driven trading in NDAQ from this input.
For ASX:TUA, the key valuation issue is not near-term subscriber growth but whether regulatory remediation becomes a recurring cost center and constrains strategic flexibility. A permanent increase in security, compliance, and spectrum-governance costs would reduce the incremental EBITDA conversion that a challenger telecom needs to justify a growth multiple; failed consolidation also leaves TUA competing against better-scaled incumbents that can selectively match pricing. Conversely, a clean regulatory resolution would turn excess cash from a stranded acquisition reserve into a capital-return, bolt-on, or network-investment catalyst, but that requires independent clarity on sanctions, operating restrictions, and the recurring versus one-off nature of remediation spend.
The contrarian case is that the equity may be discounting a severe regulatory outcome before the regulator has established one. However, low-price telecom customer bases are inherently vulnerable when competitors narrow plan-price gaps, so a rebound should be earned through stabilizing net adds and demonstrated ARPU discipline rather than inferred from headline profitability alone. Over the next 1-3 months, regulator communications and FY27 cost framing dominate; over 6-18 months, the decisive variable is whether fixed/enterprise mix can lift revenue per connection faster than compliance and competitive costs rise.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Key Decisions for Investors
- Do not trade NDAQ on this item; classify the ticker/article linkage as a data-quality exception and require a corrected issuer identifier before any model-driven action.
- For ASX:TUA, remain on watch rather than initiate ahead of regulatory disclosure. Consider a small long only after the regulator confirms no material operating or spectrum restriction and management quantifies recurring compliance expense; target at least 2:1 upside/downside based on normalized EBITDA after those costs.
- Use the recent low as a technical risk marker only after confirming the correct trading currency and venue. A sustained break below that level without a regulatory resolution would indicate that the market is repricing business-model risk rather than reacting to a one-off cost event.
- For a 1-3 month catalyst trade, monitor monthly/quarterly net adds, mobile ARPU, and broadband mix. Avoid averaging down if net additions decelerate while ARPU declines, as that combination would falsify the operating-leverage thesis even if revenue continues to grow.
- Watch Singapore incumbents Singtel (SGX:Z74) and StarHub (SGX:CC3) for promotional intensity. Persistent price matching or elevated retention spending would weaken TUA's margin-recovery setup and favor incumbent scale economics over the challenger.
More News
- Meta's standoff with Amazon over Muse could be a sign of things to come
- Anthropic Could Join the Nasdaq-100 Only 15 Trading Days After Its IPO, Just Like SpaceX Did
- History rhymes for Meta, and our plan for Micron ahead of earnings
- United Therapeutics at Bernstein forum: growth bets widen
- SpaceX Can't Join the S&P 500 Before June 2027 -- and Its Losses Could Keep It Out Longer
- ONE Nuclear completes SPAC merger, to trade as ONEN on Nasdaq
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Analyze SEC Filings With AI: A Verification-First Guide
- AI for IR Street Intelligence: Notes, Estimates, and Peers